Variant 1
1. Amenorrhea: Definition; Primary & Secondary Amenorrhea ? Physiological Amenorrhea ?
2. Endometriosis: Investigations
3. Bacterial vaginosis: treatment
1. Amenorrhea:
Amenorrhea refers to the absence of menstrual periods in a woman of reproductive age. It can occur due to various
factors, including hormonal imbalances, pregnancy, breastfeeding, certain medical conditions, or lifestyle factors.
Primary Amenorrhea:
Primary amenorrhea is diagnosed when a girl has not experienced her first menstrual period (menarche) by the
age of 15-16 years, or by the age of 13-14 years if she has not shown any signs of puberty, such as breast
development or pubic hair growth. It can be caused by genetic disorders, hormonal abnormalities, structural
abnormalities of the reproductive organs, or other underlying conditions.
Secondary Amenorrhea:
Secondary amenorrhea refers to the absence of menstrual periods in a woman who previously had regular
menstrual cycles. It is diagnosed when a woman misses her periods for three consecutive cycles or more, or for a
period of six months or longer. Common causes of secondary amenorrhea include pregnancy, hormonal imbalances
(such as polycystic ovary syndrome or thyroid disorders), excessive exercise, stress, certain medications, and certain
medical conditions.
Physiological Amenorrhea:
Physiological amenorrhea refers to a normal, temporary absence of menstrual periods due to specific life stages or
conditions. Some examples of physiological amenorrhea include:
•
•
•
•
Prepubertal amenorrhea: Girls who have not reached puberty yet.
Pregnancy: During pregnancy, menstruation stops due to the hormonal changes supporting pregnancy.
Lactational amenorrhea: Exclusive breastfeeding can cause temporary suppression of ovulation and
menstruation in some women.
Perimenopause and menopause: As women approach menopause, there is a natural decline in reproductive
hormones, leading to irregular periods and eventual cessation of menstruation.
2. Endometriosis Investigations :
• Medical History and Symptoms: The doctor will first gather your medical history and inquire about your
symptoms, including the nature and intensity of the pain, menstrual patterns, and any other associated
symptoms.
• Pelvic Examination: A pelvic exam allows the doctor to manually check for abnormalities, such as palpable
masses or tender areas, which may indicate the presence of endometriosis. However, it's important to note
that endometriosis cannot be definitively diagnosed through a pelvic exam alone.
• Imaging Tests: Various imaging techniques can help visualize structures within the pelvis and identify
possible signs of endometriosis. These tests may include transvaginal ultrasound, MRI (magnetic resonance
imaging), or CT (computed tomography) scan.
• Laparoscopy: Laparoscopy is considered the gold standard for diagnosing endometriosis. It is a surgical
procedure performed under general anesthesia in which a small incision is made near the navel, and a
thin, lighted instrument called a laparoscope is inserted to examine the pelvic organs. During laparoscopy,
the doctor can directly visualize and biopsy endometrial tissue to confirm the presence of endometriosis.
3. Bacterial Vaginosis Treatment:
1
•
•
•
Bacterial vaginosis (BV) is a common vaginal infection caused by an imbalance of bacteria in the vagina. It is
typically characterized by symptoms such as a fishy odor, abnormal vaginal discharge, and itching. Treatment
for bacterial vaginosis usually involves the use of antibiotics.
Some common approaches to treating BV:
Metronidazole: This is the most commonly prescribed antibiotic for BV. It can be taken orally in pill form or
applied topically as a gel or cream directly to the vagina.
Clindamycin: Another antibiotic used to treat bacterial vaginosis, clindamycin is available as a cream that is
applied inside the vagina.
Tinidazole: This antibiotic is an alternative to metronidazole and may be used if the infection does not respond to
other treatments. Tinidazole is usually taken orally.
Variant 2
1. Diagnostics of ovulation ?
2. Infertility: definition. Risk factors ?
3. Ectopic pregnancy: treatment ?
1. The main methods used to diagnose ovulation include:
•
•
•
•
Basal Body Temperature (BBT) charting: This involves tracking your body temperature every morning
before getting out of bed. A slight increase in temperature after ovulation indicates that ovulation has
occurred.
Ovulation predictor kits (OPKs): These kits detect the surge in luteinizing hormone (LH) that triggers
ovulation. A positive result suggests that ovulation is likely to occur within the next 24-36 hours.
Transvaginal ultrasound: This imaging technique can help visualize the ovaries and monitor the growth and
release of a mature follicle, indicating ovulation is imminent.
Hormone blood tests: Levels of certain hormones, such as progesterone, can be measured to confirm
ovulation. A significant rise in progesterone after ovulation is a strong indication that it has taken place.
2. Definition: Infertility is defined as the inability to conceive after actively trying to conceive for at least one year
(or six months for women over 35) without the use of contraception. It can be caused by various factors, and some
common risk factors for infertility include:
•
•
•
•
•
•
Age: Fertility declines with age, particularly for women over 35. Advanced maternal age is associated with a
decrease in the number and quality of eggs.
Hormonal disorders: Conditions such as polycystic ovary syndrome (PCOS) or thyroid disorders can disrupt
ovulation and affect fertility.
Structural abnormalities: Issues like blocked fallopian tubes, uterine abnormalities, or fibroids can interfere
with the fertilization process or implantation of the embryo.
Male factor infertility: Male factors, such as low sperm count or abnormal sperm function, contribute to
infertility in about 40% of cases.
Lifestyle factors: Certain lifestyle choices, including smoking, excessive alcohol consumption, obesity, and
high levels of stress, can negatively impact fertility.
Medical conditions: Conditions like endometriosis, pelvic inflammatory disease (PID), or certain cancers
and their treatments can affect fertility.
3. Ectopic pregnancy: Treatment:
An ectopic pregnancy occurs when a fertilized egg implants outside the uterus, usually in the fallopian tube. The
treatment options for ectopic pregnancy include:
•
Medication: If the ectopic pregnancy is detected early and stable, a medication called methotrexate may be
given. Methotrexate stops the growth of the embryo and allows the body to reabsorb it. Close monitoring
is required to ensure the treatment is successful.
2
•
Surgery: If the ectopic pregnancy is advanced, ruptured, or the medication is not suitable, surgery may be
necessary. The most common surgical approach is laparoscopy, where a small incision is made to remove
the ectopic pregnancy while preserving the fallopian tube if possible. In severe cases, an open surgery
called laparotomy may be performed.
Variant 3
1. AUB: definition?
2. Endometriosis: Risk factors ?
3. Fibroid: indication for surgical treatment ?
1. AUB stands for Abnormal Uterine Bleeding. It refers to any atypical or irregular bleeding that occurs from the
uterus. This can include heavy or prolonged menstrual periods, bleeding between periods, or bleeding after
menopause. AUB can have various causes, such as hormonal imbalances, uterine fibroids, polyps, endometrial
hyperplasia, or certain medical conditions. It is important to evaluate the underlying cause of AUB in order to
determine appropriate treatment.
2. Endometriosis is a condition in which the tissue that normally lines the inside of the uterus (the endometrium)
grows outside the uterus. While the exact cause of endometriosis is unknown, several risk factors includes:
•
•
•
•
•
Family history: Having a close relative (such as a mother, sister, or aunt) with endometriosis increases the risk.
Retrograde menstruation: This occurs when menstrual blood containing endometrial cells flows back through
the fallopian tubes and into the pelvic cavity, leading to the implantation of these cells in the pelvic organs.
Hormonal imbalance: Increased levels of estrogen or an imbalance between estrogen and progesterone may
contribute to the development of endometriosis.
Reproductive history: Women who have never given birth or have a short menstrual cycle are at a higher risk.
Other factors: Certain immune system disorders, abnormal pelvic structure, and environmental factors may
also play a role.
3. The surgical treatment of fibroids (also known as uterine fibroids or leiomyomas) depends on various factors,
including the symptoms experienced by the patient, the size and location of the fibroids, and the desire for future
fertility. Surgical options for fibroids include:
•
•
•
•
•
Myomectomy: This procedure involves the removal of the fibroids while preserving the uterus. It is typically
recommended for women who wish to preserve their fertility or have symptomatic fibroids that require
treatment.
Hysterectomy: In cases where fertility is not a concern or when conservative treatments have failed, a
hysterectomy may be recommended. This surgery involves the complete removal of the uterus, and in some
cases, the cervix as well.
Uterine artery embolization (UAE): This minimally invasive procedure involves blocking the blood supply to the
fibroids, causing them to shrink. It is a non-surgical alternative to myomectomy or hysterectomy.
Magnetic resonance-guided focused ultrasound surgery (MRgFUS): This is another non-invasive option that
uses high-intensity ultrasound waves to destroy the fibroids.
Endometrial ablation: In cases where the fibroids primarily cause heavy menstrual bleeding, endometrial
ablation may be considered. This procedure destroys the lining of the uterus, reducing or eliminating menstrual
bleeding.
Variant 4
1. PID: Definition and Risk factors
2. Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome:
3. Chlamydia Treatment
3
1. Definition: Pelvic Inflammatory Disease is an infection that affects the female reproductive organs, including the
uterus, fallopian tubes, and ovaries. It is typically caused by bacteria, most commonly from sexually transmitted
infections (STIs) such as gonorrhea and chlamydia.
Risk factors for PID include:
•
•
•
•
•
Multiple sexual partners: Having multiple sexual partners increases the risk of exposure to STIs, which can
lead to PID.
Unprotected sex: Engaging in sexual activity without using barrier methods, such as condoms, can increase
the risk of contracting STIs and developing PID.
Previous history of PID: A prior episode of PID increases the likelihood of developing it again.
Young age at first intercourse: Starting sexual activity at a younger age may increase the risk of exposure to
STIs and subsequent PID.
Intrauterine device (IUD) use: Although rare, there is a slightly increased risk of PID in the first few weeks
after IUD insertion.
2. Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome:
MRKH syndrome is a rare congenital disorder that affects the female reproductive system. It is characterized by the
incomplete development or absence of the uterus and upper part of the vagina, while the external genitalia
appear normal. Key points about MRKH syndrome include:
•
•
•
•
Diagnosis: MRKH syndrome is typically diagnosed in adolescence when a young woman does not start
menstruating (primary amenorrhea) and seeks medical attention. Physical examination, imaging tests (such as
ultrasound or MRI), and sometimes genetic testing are used for diagnosis.
Psychological support: The diagnosis of MRKH syndrome can have a significant emotional impact. Psychological
support, counseling, and support groups can be beneficial for individuals and their families in coping with the
diagnosis.
Treatment: Treatment options for MRKH syndrome mainly focus on addressing the absence of the uterus and
vagina to enable sexual function and potential fertility. Surgical procedures, such as neovaginoplasty or
creation of a vaginal canal using tissue grafts, can be performed. However, these procedures do not restore
reproductive capabilities, and assisted reproductive technologies (such as gestational surrogacy) may be
considered for achieving pregnancy.
Overall health: It is important for individuals with MRKH syndrome to have regular check-ups and discussions
with healthcare providers to address any associated health concerns and ensure emotional well-being.
3. Chlamydia Treatment:
Chlamydia is a common sexually transmitted infection caused by the bacterium Chlamydia trachomatis. It can lead
to various complications if left untreated. Treatment typically involves the following:
•
•
•
•
Antibiotics: Chlamydia can be effectively treated with antibiotics. The most commonly prescribed antibiotics for
chlamydia are azithromycin or doxycycline. These medications are usually taken orally as a single dose or a
course of treatment over several days.
Partner notification and treatment: It is important to inform sexual partners about the infection so they can be
tested and treated if necessary. This helps prevent reinfection and further transmission.
Follow-up testing: It is recommended to have a follow-up test after completion of treatment to ensure the
infection has cleared. This is particularly important in cases of persistent or recurrent symptoms.
Abstaining from sexual activity: During treatment, it is important to abstain from sexual activity, including
vaginal, anal, and oral sex, to avoid transmitting the infection to others.
Additionally, it’s recommended to undergo retesting for chlamydia three months after treatment, especially for
individuals at higher risk or those who had unprotected sex during the treatment period.
4
Variant 5
1. Endometriosis : definition and types?
2. Anovulation: Laboratory tests ?
3. Complications of PID
1. Endometriosis is a condition in which the tissue that normally lines the inside of the uterus, called the
endometrium, grows outside the uterus. This abnormal tissue growth can occur on the ovaries, fallopian tubes,
outer surface of the uterus, or other organs in the pelvic cavity. Endometriosis lesions respond to hormonal
changes in the same way as the lining of the uterus, leading to inflammation, scarring, and the formation of
adhesions.
There are several types of endometriosis based on the location and severity of the lesions:
•
•
•
•
Superficial peritoneal endometriosis: This type involves small, shallow lesions on the peritoneum (the lining
of the pelvic cavity).
Ovarian endometriosis: Endometriosis can form cysts called endometriomas on the ovaries, also known as
“chocolate cysts” due to their dark, thick fluid contents.
Deep infiltrating endometriosis (DIE): This type involves deep lesions that penetrate into the surrounding
tissues, such as the bowel, bladder, or ligaments.
Adenomyosis: Although not strictly a type of endometriosis, adenomyosis is a related condition where the
endometrial tissue grows into the muscular wall of the uterus, causing pain and heavy menstrual bleeding.
2. Anovulation refers to a condition in which a woman does not ovulate or release an egg from the ovaries during
her menstrual cycle. It can lead to menstrual irregularities or even the absence of menstruation (amenorrhea).
Some of the common laboratory tests include:
• Hormone level testing: Blood tests can measure hormone levels, such as follicle-stimulating hormone (FSH),
luteinizing hormone (LH), estradiol, and progesterone. Abnormal levels can indicate hormonal imbalances
that affect ovulation.
• Thyroid function tests: Thyroid hormones play a role in regulating the menstrual cycle. Testing for thyroidstimulating hormone (TSH), thyroxine (T4), and triiodothyronine (T3) can help assess thyroid function.
• Prolactin level testing: High levels of prolactin, a hormone involved in lactation, can disrupt ovulation. Blood
tests can measure prolactin levels.
• Anti-Mullerian hormone (AMH) testing: AMH is a hormone produced by developing follicles in the ovaries.
Testing AMH levels can provide an estimate of a woman’s ovarian reserve, which can help evaluate fertility
potential.
3. PID (Pelvic Inflammatory Disease) is an infection of the female reproductive organs, primarily the uterus,
fallopian tubes, and ovaries. If left untreated, PID can lead to various complications, including:
• Tubo-ovarian abscess: This is a collection of pus that forms in the fallopian tubes and ovaries. It may
require surgical drainage and can lead to long-term damage and fertility problems.
• Infertility: PID can cause scarring and blockage of the fallopian tubes, preventing the fertilization of eggs by
sperm. This can result in difficulty conceiving or an increased risk of ectopic pregnancy (when a fertilized
egg implants outside the uterus).
• Chronic pelvic pain: PID can cause ongoing pain in the pelvic region, which may be intermittent or constant.
The pain can interfere with daily activities and significantly affect quality of life.
• Pelvic adhesions
5
Variant 6
1. Fibroid: Definition and Risk factors ?
2. Adenomyosis: medical management?
3. Chlamydia trachomatis: Laboratory test ?
1. Definition: Fibroids, also known as uterine fibroids or leiomyomas, are noncancerous growths that develop in the
uterus. They are composed of muscle tissue and can vary in size, number, and location within the uterus.
Risk factors associated with fibroids include:
•
•
•
•
•
Age: Fibroids are more common in women of reproductive age, with the likelihood of developing fibroids
decreasing after menopause.
Family history: Having a family history of fibroids increases the risk of developing them.
Hormonal factors: Estrogen and progesterone, the hormones involved in the menstrual cycle, can promote
the growth of fibroids. Thus, hormone-related conditions such as early onset of menstruation, hormonal
imbalances, and hormonal replacement therapy may increase the risk.
Ethnicity: Fibroids are more common in women of African descent compared to other ethnic groups.
Obesity: Excess body weight is associated with an increased risk of fibroids.
Symptoms of fibroids can include heavy or prolonged menstrual bleeding, pelvic pain or pressure, frequent
urination, and reproductive issues.
2. Adenomyosis is a condition in which the tissue lining the uterus (endometrium) grows into the muscular wall of
the uterus (myometrium). It can cause symptoms such as heavy or prolonged menstrual bleeding, severe
menstrual cramps, and pelvic pain.
Medical management of adenomyosis may involve:
•
•
•
•
Pain relief: Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, can help alleviate pain and
reduce inflammation associated with adenomyosis.
Hormonal therapy: Hormonal medications, such as birth control pills, progestins, or gonadotropin-releasing
hormone (GnRH) agonists, may be prescribed to help manage symptoms. These medications can help
regulate the menstrual cycle, reduce bleeding, and relieve pain.
Uterine artery embolization (UAE): In this procedure, tiny particles are injected into the blood vessels
supplying the uterus to block blood flow to the adenomyosis-affected areas. This can help shrink the
adenomyosis and alleviate symptoms.
Hysterectomy: In severe cases, when symptoms are not manageable with conservative measures and
fertility is not a concern, a hysterectomy (surgical removal of the uterus) may be recommended as a
definitive treatment for adenomyosis.
3. Laboratory Test: used to diagnose Chlamydia trachomatis, the bacterium responsible for the sexually transmitted
infection (STI) chlamydia.
The two main types of laboratory tests for chlamydia include:
•
•
Nucleic Acid Amplification Tests (NAATs): NAATs are highly sensitive and specific tests that detect the
genetic material (DNA or RNA) of the chlamydia bacteria. These tests can be performed on urine samples,
swabs taken from the cervix, urethra, rectum, or throat. NAATs are considered the gold standard for
chlamydia testing.
Enzyme immunoassays (EIAs): EIAs detect specific chlamydia antigens (proteins) in the body’s fluid
samples, such as urine or swabs from the affected areas. These tests are rapid and can provide quick
results, but they may have slightly lower sensitivity compared to NAATs.
6
Variant 7
1. Classification of AUB PALM-COEIN?
2. differential diagnosis of PID and appendicitis ?
3. Ectopic pregnancy: risk factors
1. AUB PALM-COEIN is a classification system used to categorize the causes of Abnormal Uterine Bleeding (AUB).
Each letter in the acronym represents a different category:
- PALM:
•
•
•
•
Polyp: Refers to the presence of uterine or cervical polyps, which are benign growths.
Adenomyosis: Involves the presence of endometrial tissue within the muscular wall of the uterus.
Leiomyoma: Refers to uterine fibroids, which are non-cancerous tumors of the uterine muscle.
Malignancy: Represents the possibility of endometrial or cervical cancer.
- COEIN:
•
•
•
•
•
Coagulopathy: Refers to bleeding disorders or abnormalities in blood clotting factors.
Ovulatory dysfunction: Involves hormonal imbalances that disrupt normal ovulation.
Endometrial: Refers to endometrial conditions such as hyperplasia (overgrowth of the uterine lining) or
cancer.
Iatrogenic: Represents AUB caused by medical interventions or treatments.
Not yet classified: In some cases, the cause of AUB may not fit into any of the above categories.
2. PID (Pelvic Inflammatory Disease) and appendicitis are two different conditions that can have overlapping
symptoms. Some distinguishing factors include:
•
PID: Pelvic pain is a hallmark symptom of PID and is typically localized to the lower abdomen. It may be
accompanied by abnormal vaginal discharge, pain during intercourse, fever, and irregular menstrual
bleeding. PID often presents with tenderness upon pelvic examination. Risk factors for PID include a history
of sexually transmitted infections (STIs), multiple sexual partners, and intrauterine device (IUD) use.
•
Appendicitis: Appendicitis usually presents with pain that starts around the navel and migrates to the
lower right abdomen. Other symptoms may include nausea, vomiting, loss of appetite, fever, and rebound
tenderness at the site of the appendix. Appendicitis can be diagnosed through physical examination, blood
tests, and imaging studies such as ultrasound or CT scan.
Although both conditions can cause abdominal pain and are considered medical emergencies, the treatment
approaches differ. PID is typically treated with antibiotics, while appendicitis usually requires surgical removal of
the inflamed appendix.
3. Ectopic pregnancy refers to a pregnancy in which the fertilized egg implants and develops outside the uterus,
most commonly within the fallopian tube. Several risk factors increase the likelihood of ectopic pregnancy:
• Previous ectopic pregnancy: Having experienced an ectopic pregnancy in the past increases the risk of
having another one.
• Previous pelvic surgery: Surgeries involving the fallopian tubes, such as tubal ligation or surgery for tubal
infections, can increase the risk of ectopic pregnancy.
• Pelvic inflammatory disease (PID): Infections of the reproductive organs, particularly the fallopian tubes,
can cause scarring or damage, increasing the chances of ectopic pregnancy.
• History of infertility or fertility treatments: Women who have struggled with infertility or have undergone
fertility treatments, such as in vitro fertilization (IVF), may have a higher risk of ectopic pregnancy.
7
•
•
Tubal abnormalities: Structural abnormalities of the fallopian tubes, either congenital or acquired, can
hinder the proper movement of the fertilized egg, leading to ectopic pregnancy.
Maternal age: The risk of ectopic pregnancy tends to increase with age, particularly after the age of 35.
It’s important to note that ectopic pregnancy cannot be prevented
Variant 8
1. PID: outpatient treatment ?
2. FSH and E2 levels in women with turner syndrome in reproductive age?
3. Menstrual cycle: role and time of LH – SURGE
1. Outpatient treatment typically involves a combination of oral antibiotics to target the specific organisms causing
the infection. Commonly used antibiotics for outpatient PID treatment include a combination of ceftriaxone (a
third-generation cephalosporin) and doxycycline (a tetracycline antibiotic).
2. Women with Turner syndrome, a genetic condition in which one of the X chromosomes is partially or
completely missing, often experience ovarian dysfunction and infertility. Typically, women with Turner syndrome
have elevated levels of FSH and reduced levels of E2. The elevated FSH indicates decreased ovarian reserve and
diminished follicular development. The reduced E2 levels reflect impaired estrogen production by the ovaries.
These hormonal imbalances contribute to the infertility commonly observed in women with Turner syndrome.
3. The menstrual cycle is regulated by a complex interplay of hormones, including luteinizing hormone (LH) and
follicle-stimulating hormone (FSH). LH plays a crucial role in triggering ovulation, which is the release of a
mature egg from the ovary. The LH surge refers to a rapid and significant increase in LH levels that occurs just
before ovulation.
The timing of the LH surge is critical for successful conception. On average, the LH surge occurs around 24 to 36
hours before ovulation. It serves as a signal for the dominant follicle in the ovary to rupture and release the mature
egg. The surge in LH triggers a series of events that lead to the release of the egg and its readiness for fertilization.
Tracking the LH surge can be useful for women trying to conceive. By monitoring the LH surge, women can identify
their fertile window and increase the chances of successful conception by timing intercourse accordingly.
Variant 9
1. Turner syndrome: causes , symptoms and treatment ?
2. Differential diagnosis of PID and ectopic pregnancy
3. Submucosal myoma : management
1. Turner syndrome is a genetic disorder that affects females and occurs due to the absence or abnormalities of the
second X chromosome. It is typically characterized by short stature, delayed or absent puberty, and infertility.
•
•
Causes: Turner syndrome occurs when one of the two X chromosomes is missing or partially missing. This can
happen due to various genetic abnormalities, including complete monosomy X (45,X), mosaic Turner syndrome
(45,X/46,XX), or structural abnormalities of the X chromosome.
Symptoms: The symptoms and severity of Turner syndrome can vary. Common signs and symptoms include short
stature, delayed growth and puberty, webbed neck, low-set ears, broad chest, heart and kidney abnormalities,
8
•
infertility, learning difficulties, and certain physical features such as widely spaced nipples and swollen hands
and feet.
Treatment: Treatment for Turner syndrome aims to manage associated symptoms and optimize overall health.
It may involve hormone replacement therapy (estrogen and progesterone) to induce puberty and promote
normal sexual development, growth hormone therapy to enhance height, and assisted reproductive
techniques for fertility preservation. Additional interventions may be needed to address specific medical
concerns, such as heart or kidney abnormalities.
2. The differential diagnosis of PID includes:
•
•
•
Ovarian Cyst: An ovarian cyst is a fluid-filled sac that develops on or within the ovary. It can cause similar
symptoms to PID, such as pelvic pain and discomfort. Imaging studies, such as ultrasound, can help
differentiate between the two conditions.
Appendicitis: In some cases, appendicitis (inflammation of the appendix) can cause symptoms that mimic
PID. The location of pain and other clinical findings, along with imaging studies like ultrasound or computed
tomography (CT) scan, can help differentiate between the two.
Urinary Tract Infection (UTI): Lower urinary tract infections, particularly involving the bladder (cystitis), can
present with symptoms similar to PID. A urine culture and analysis can help identify the presence of
bacteria and determine if a UTI is the cause of symptoms.
The differential diagnosis of ectopic pregnancy includes:
•
•
•
Acute Appendicitis: In rare cases, an ectopic pregnancy can mimic the symptoms of acute appendicitis. A
thorough evaluation, including imaging studies and assessment of beta-hCG levels, can help differentiate
between the two conditions.
Corpus Luteum Cyst: A corpus luteum cyst is a type of ovarian cyst that can sometimes cause symptoms
similar to ectopic pregnancy. Imaging studies and serial beta-hCG measurements can aid in distinguishing
between the two.
Spontaneous Abortion (Miscarriage): In some cases, a miscarriage can be mistaken for an ectopic pregnancy,
especially if the pregnancy is very early and the location of the gestational sac cannot be visualized.
Transvaginal ultrasound and serial beta-hCG measurements can help differentiate between the two
conditions.
3. Submucosal Myoma: Management:
Submucosal myomas are noncancerous tumors that grow in the muscle layer beneath the lining of the uterus
(submucosa). They can cause heavy or prolonged menstrual bleeding, pain, and fertility issues.
Treatment options may include:
•
•
•
Hysteroscopic Myomectomy: This minimally invasive surgical procedure involves removing the submucosal
myoma through the cervix and uterus using a hysteroscope. The hysteroscope is a thin, lighted instrument
that allows the surgeon to visualize and remove the myoma while preserving the uterus. Hysteroscopic
myomectomy is the preferred treatment for symptomatic submucosal myomas, particularly for those
causing significant menstrual bleeding or fertility issues.
Medications: Medications such as gonadotropin-releasing hormone (GnRH) agonists or selective
progesterone receptor modulators (SPRMs) may be used to temporarily shrink the submucosal myoma and
improve symptoms. These medications are typically used before surgical intervention to reduce the size of
the myoma and facilitate a less invasive procedure.
Uterine Artery Embolization (UAE): This procedure involves blocking the blood supply to the myoma by
injecting tiny particles into the uterine arteries. By cutting off the blood flow, the myoma shrinks, leading
to symptom relief. UAE is generally used for larger myomas that cannot be easily removed through
hysteroscopy or for individuals who want to avoid surgery.
9
•
Hysterectomy: In cases where fertility is not a concern or when conservative treatments fail or are not
suitable, a hysterectomy may be recommended. A hysterectomy involves the surgical removal of the uterus,
and it provides a definitive solution for submucosal myomas.
Variant 10
1. Amenorrhea: investigations
2. Minimum criteria for diagnosis of acute PID
3. AUB: principles of treatment
1. Amenorrhea refers to the absence of menstrual periods in women of reproductive age.
Investigations include:
•
•
•
•
•
Medical History and Physical Examination: The healthcare provider will gather information about the
individual's menstrual history, any associated symptoms, and relevant medical history. They will also perform
a physical examination to assess for any signs of hormonal imbalances or physical abnormalities.
Pregnancy Test: A pregnancy test is typically the first step in evaluating amenorrhea to rule out pregnancy
as the cause. It can be done using a urine or blood sample.
Hormonal Assessment: Blood tests may be conducted to measure hormone levels, including folliclestimulating hormone (FSH), luteinizing hormone (LH), estrogen, progesterone, thyroid-stimulating
hormone (TSH), and prolactin. These tests help evaluate hormonal imbalances and identify conditions such
as polycystic ovary syndrome (PCOS), hypothalamic dysfunction, or thyroid disorders.
Imaging Studies: Depending on the clinical suspicion and findings, imaging studies like ultrasound, magnetic
resonance imaging (MRI), or computed tomography (CT) scan may be recommended. These tests can help
identify structural abnormalities in the reproductive organs or evaluate the presence of ovarian cysts or
tumors.
Other Specialized Tests: In certain cases, additional tests may be required to investigate specific causes of
amenorrhea, such as genetic testing, adrenal function tests, or pelvic laparoscopy to visualize the
reproductive organs directly.
2. Acute Pelvic Inflammatory Disease (PID) is an infection of the female reproductive organs, usually caused by
sexually transmitted bacteria such as Chlamydia trachomatis or Neisseria gonorrhoeae.
The diagnosis of acute PID is typically based on a combination of clinical criteria, which may include:
•
•
•
Lower Abdominal Pain: Presence of pelvic or lower abdominal pain, which may range from mild to severe.
Uterine Tenderness: Tenderness or pain upon examination of the uterus during a pelvic examination.
Adnexal Tenderness: Tenderness or pain upon examination of the ovaries or fallopian tubes during a pelvic
examination.
Additional findings that support the diagnosis of acute PID include:
•
•
•
Cervical Motion Tenderness: Pain or tenderness with movement of the cervix during a pelvic examination.
Abnormal Vaginal or Cervical Discharge: Presence of abnormal vaginal discharge or cervical discharge, often
described as an unusual color, odor, or consistency.
Elevated Inflammatory Markers: Laboratory tests may reveal an elevated white blood cell count
(leukocytosis) or an elevated C-reactive protein (CRP) level, indicating inflammation.
3. AUB (Abnormal Uterine Bleeding): Principles of Treatment:
10
•
•
•
•
•
Hormonal Therapy: Hormonal therapy is often used as a first-line treatment for AUB. It aims to regulate the
menstrual cycle, reduce bleeding, and alleviate symptoms. Different hormonal options include:
o Combined Oral Contraceptives: These contain both estrogen and progestin and help regulate the
menstrual cycle.
o Progestin-Only Therapy: Progestin-only pills, hormonal intrauterine devices (IUDs), or progestin
injections can help control bleeding in some cases.
o GnRH Agonists: These medications suppress ovarian function and are used in severe cases of AUB
to induce a temporary menopausal state and control bleeding.
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): NSAIDs, such as ibuprofen, can help reduce menstrual
bleeding and alleviate pain by inhibiting prostaglandin production.
Endometrial Ablation: In cases where hormonal therapy is ineffective or not suitable, endometrial ablation
may be considered. It is a procedure that removes or destroys the lining of the uterus (endometrium) to
reduce menstrual bleeding. It is typically a minimally invasive procedure performed under anesthesia.
Surgical Interventions: Surgery may be recommended in cases where conservative treatments fail or when
there are structural abnormalities causing AUB. Surgical options include:
o Hysterectomy: Removal of the uterus is considered a definitive treatment for AUB and is typically
considered when fertility is no longer desired.
o Myomectomy: Surgical removal of uterine fibroids if they are causing AUB.
o Polypectomy: Removal of endometrial polyps that may contribute to AUB.
Treatment of Underlying Conditions: If AUB is caused by an underlying condition such as polycystic ovary
syndrome (PCOS), thyroid disorders, or endometriosis, treatment of the underlying condition is essential to
manage AUB effectively.
Variant 11
1. Endometriosis: Indications for surgical treatment ?
2. Progesterone levels during menstrual cycle ?
3. Definitive criteria for diagnosis of PID ?
1. Surgical treatment for endometriosis may be considered in the following situations:
•
•
•
•
Severe Symptoms: Surgical intervention is often recommended for individuals with severe pain, significant
impairment of daily activities, or infertility caused by endometriosis.
Failure of Conservative Management: If symptoms persist or worsen despite conservative treatments such as
hormonal therapy (e.g., oral contraceptives, progestins) or pain management, surgery may be considered.
Presence of Deep Infiltrating Endometriosis (DIE): Deep infiltrating endometriosis refers to endometriotic
lesions that infiltrate deeply into the surrounding tissue, such as the bowel, bladder, or pelvic structures.
Surgical excision or resection of these lesions may be necessary to relieve pain and improve quality of life.
Infertility: Surgical treatment may be indicated in cases where endometriosis is suspected to be a cause of
infertility. Procedures such as laparoscopic surgery, including excision of endometriotic lesions, removal of
adhesions, and restoration of normal pelvic anatomy, can improve fertility outcomes.
2. Progesterone levels fluctuate during the menstrual cycle. General overview of progesterone levels during different
phases of the menstrual cycle:
•
•
Follicular Phase: In the early phase of the menstrual cycle, progesterone levels are relatively low. After
menstruation, as the follicles in the ovary start to develop, progesterone gradually increases.
Ovulation: Progesterone levels rise sharply after ovulation. This surge in progesterone helps prepare the
uterus for possible implantation of a fertilized egg.
11
•
Luteal Phase: Following ovulation, progesterone levels remain elevated during the luteal phase of the
menstrual cycle. If pregnancy occurs, progesterone levels continue to rise to support the early stages of
pregnancy. If pregnancy does not occur, progesterone levels decrease, leading to menstruation.
3. The diagnosis of Pelvic Inflammatory Disease (PID) is typically based on a combination of clinical criteria and
laboratory findings. The minimum criteria include:
•
•
•
Lower Abdominal Pain: Presence of pelvic or lower abdominal pain is a key symptom of PID. The pain may
be mild to severe and can be constant or intermittent.
Cervical Motion Tenderness: Pain or tenderness when the cervix is moved during a pelvic examination is an
important clinical sign suggestive of PID.
Uterine Tenderness: Tenderness or pain upon examination of the uterus during a pelvic examination may
indicate inflammation.
Additional criteria that support the diagnosis of PID include:
•
•
•
Adnexal Tenderness: Tenderness or pain upon examination of the ovaries or fallopian tubes during a pelvic
examination.
Abnormal Vaginal or Cervical Discharge: Presence of abnormal vaginal discharge or cervical discharge, often
described as an unusual color, odor, or consistency.
Laboratory Findings: Laboratory tests may be conducted to support the diagnosis of PID. These can include:
o Elevated C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR), which indicate
inflammation.
o White blood cell (WBC) count may be elevated.
o Microbiological testing to identify the causative organisms, such as Chlamydia trachomatis or
Neisseria gonorrhoeae, through nucleic acid amplification tests (NAATs) or cultures.
Variant 12
1. Infertility: Definition; Primary and Secondary infertility ?
2. Pre-mature ovarian failure: symptoms and laboratory tests ?
3. PID: Hydrosalpinx, Definition, diagnostics and management
1. Definition : Infertility is the inability to conceive or achieve a successful pregnancy after trying for a certain
period of time (usually one year for couples under 35, and six months for couples over 35) without using any
contraception. It is important to note that infertility is a couple-based diagnosis, meaning it involves both the
male and female partners.
• Primary Infertility: Primary infertility refers to the inability to conceive or achieve a successful pregnancy in
a couple who have never had a child before.
• Secondary Infertility: Secondary infertility refers to the inability to conceive or achieve a successful
pregnancy in a couple who have had a previous child or children without any reproductive assistance but
are now experiencing difficulty conceiving again.
2. Premature Ovarian Failure, also known as premature ovarian insufficiency, is a condition in which the ovaries
stop functioning before the age of 40. This can lead to a decline in ovarian follicles and a decrease in hormone
production, particularly estrogen.
Symptoms of POF may include:
12
•
•
•
•
•
•
•
Irregular or absent menstrual periods
Hot flashes and night sweats
Vaginal dryness
Decreased sex drive
Mood swings and irritability
Difficulty concentrating
Infertility
Laboratory tests that may be used to diagnose POF include:
•
•
•
Hormone Levels: Blood tests to measure levels of follicle-stimulating hormone (FSH), luteinizing hormone
(LH), estrogen, and anti-Mullerian hormone (AMH). In POF, FSH levels are typically elevated, indicating a
decreased ovarian reserve.
Genetic Testing: Genetic testing may be recommended to identify any chromosomal abnormalities or
genetic conditions associated with POF.
Imaging Studies: An ultrasound or pelvic imaging may be conducted to assess the size and appearance of
the ovaries.
3. Definition: Hydrosalpinx is a condition characterized by the blockage and dilation of the fallopian tube, resulting
in the accumulation of fluid within the tube. It is often caused by pelvic inflammatory disease (PID), which is an
infection that spreads to the reproductive organs.
Diagnostics for hydrosalpinx may include:
•
•
Medical History and Physical Examination: The healthcare provider will gather information about symptoms,
medical history, and risk factors. They will perform a physical examination, including a pelvic exam, to assess
for tenderness or abnormalities.
Imaging Studies: Transvaginal ultrasound or hysterosalpingography (HSG) may be used to visualize the
fallopian tubes and identify the presence of a hydrosalpinx. These imaging techniques can help determine
the location and severity of the condition.
Management of hydrosalpinx often involves addressing the underlying cause, which is typically PID. Treatment
options may include:
•
•
Antibiotic Therapy: Antibiotics are used to treat the underlying infection causing PID. It is important to
complete the full course of antibiotics as prescribed. Doxycycline.
Surgical Intervention: In cases where hydrosalpinx is severe, causes persistent symptoms, or significantly
impacts fertility, surgical treatment may be necessary. Surgical options include:
o Salpingectomy: This involves the removal of the affected fallopian tube. Salpingectomy is typically
recommended if the fallopian tube is extensively damaged or if fertility is not a concern.
o Salpingostomy: This procedure involves creating an opening in the blocked fallopian tube to drain
the accumulated fluid. Salpingostomy may be considered if fertility is desired and the fallopian
tube is not severely damaged.
o Assisted Reproductive Techniques (ART): In cases where hydrosalpinx affects fertility, and surgical
intervention is not feasible or unsuccessful, assisted reproductive techniques such as in vitro
fertilization (IVF) may be recommended. With IVF, the eggs are retrieved from the ovaries, fertilized
in the laboratory, and then transferred to the uterus, bypassing the blocked fallopian tube.
Variant 13
1. SHEEHAN SYNDROME: causes, symptoms and diagnostics ?
2. differential diagnosis of PID and UTI ?
3. Ectopic pregnancy : sites ?
13
1. Sheehan syndrome, also known as postpartum pituitary necrosis, is a condition that occurs due to severe blood
loss and low blood pressure during or after childbirth. It leads to damage or destruction of the pituitary gland,
which is responsible for producing various hormones.
• Causes: Sheehan syndrome is caused by inadequate blood supply to the pituitary gland during childbirth,
which can result from excessive bleeding (postpartum hemorrhage) or low blood pressure (hypotension)
leading to ischemia.
• Symptoms: The symptoms of Sheehan syndrome may develop gradually over time and can vary depending
on which hormones are affected. Common symptoms include:
o Failure to lactate or insufficient milk production
o Loss of pubic and underarm hair
o Fatigue and weakness
o Low blood pressure
o Weight loss or inability to gain weight
o Cold intolerance
o Menstrual irregularities or absence of menstruation (amenorrhea)
o Hypothyroidism symptoms, such as dry skin, constipation, and sensitivity to cold
Diagnostics: The diagnosis of Sheehan syndrome involves a combination of medical history, physical examination,
and laboratory tests. Tests may include hormone level measurements, including levels of follicle-stimulating
hormone (FSH), luteinizing hormone (LH), prolactin, cortisol, and thyroid-stimulating hormone (TSH). An MRI of
the brain may be done to evaluate the structure of the pituitary gland and detect any abnormalities.
2. The differential diagnosis of PID and UTI involves considering the following factors:
o
o
o
o
Symptoms: PID typically presents with lower abdominal pain, pain during intercourse, abnormal vaginal
discharge, and fever. UTI, on the other hand, commonly manifests as frequent urination, pain or burning during
urination, and a strong urge to urinate.
Physical examination: Pelvic examination in PID may reveal tenderness in the pelvic region, cervix, and uterus.
In UTI, physical examination findings are usually unremarkable.
Laboratory tests: Urine analysis and urine culture are commonly performed to diagnose UTIs. In PID, additional
tests may include a pelvic swab to check for infections, blood tests to assess inflammation markers (such as Creactive protein and erythrocyte sedimentation rate), and testing for sexually transmitted infections (STIs) if
indicated.
Imaging studies: PID may be evaluated using ultrasound or other imaging techniques to assess the pelvic
organs for any signs of inflammation or complications. UTIs typically do not require imaging studies unless there
are recurrent or complicated cases.
3. The possible sites for ectopic pregnancy include:
• Fallopian tubes: The most common site for ectopic pregnancy is within the fallopian tubes. This is referred to
as tubal ectopic pregnancy.
• Ovaries: In some cases, the fertilized egg can implant and develop within an ovary, leading to an ovarian
ectopic pregnancy.
• Cervix: Rarely, ectopic pregnancies can occur in the cervix, which is the lower part of the uterus.
• Abdominal cavity: In very rare cases, the fertilized egg can implant and develop within the abdominal cavity,
outside the reproductive organs. This is known as an abdominal ectopic pregnancy
Variant 14
1. Kallman syndrome : Causes, symptoms, diagnostics?
2. PID: Indications for hospitalization
14
3. Subserous myoma : management
1. Kallmann syndrome is a rare genetic disorder characterized by the combination of hypogonadotropic
hypogonadism (reduced function of the gonads) and anosmia (loss of the sense of smell).
Causes: Kallmann syndrome is primarily caused by genetic mutations. Mutations in several genes, including KAL1,
FGFR1, PROKR2, and PROK2, have been associated with the syndrome. These genes play a role in the development
and migration of neurons involved in the production of reproductive hormones and the sense of smell.
Symptoms: The primary symptoms of Kallmann syndrome include:
•
•
•
•
Delayed or absent puberty: Individuals with Kallmann syndrome typically experience delayed puberty or
may not undergo puberty naturally without medical intervention.
Anosmia or hyposmia: Loss of the sense of smell or reduced sense of smell is a common symptom of
Kallmann syndrome.
Hypogonadism: Decreased production of reproductive hormones, such as luteinizing hormone (LH) and
follicle-stimulating hormone (FSH), leads to underdeveloped gonads, which can result in infertility and
reduced secondary sexual characteristics.
Other associated features: Some individuals with Kallmann syndrome may have additional features like
hearing loss, cleft lip or palate, renal abnormalities, or skeletal abnormalities.
Diagnostics: The diagnosis of Kallmann syndrome involves a combination of clinical evaluation and laboratory testing,
including:
•
•
•
Medical history and physical examination: Assessing symptoms, including delayed puberty, anosmia, and
hypogonadism.
Hormonal evaluation: Blood tests to measure levels of reproductive hormones such as LH, FSH,
testosterone (in males), and estradiol (in females).
Genetic testing: Identifying mutations in genes associated with Kallmann syndrome can help confirm the
diagnosis and determine if the condition is inherited.
2. Indications for Hospitalization in cases of PID include:
•
•
•
•
•
Severe Symptoms: If the symptoms of PID are severe and the patient is experiencing intense pain, high
fever, vomiting, or signs of systemic illness, hospitalization may be necessary for closer monitoring and
management.
Pregnancy: Pregnant individuals with PID may require hospitalization to ensure appropriate treatment and
monitoring of both the mother and the developing fetus.
Surgical Considerations: If there is a suspicion of a pelvic abscess or other complications that require
surgical intervention, hospitalization may be needed.
Inability to Tolerate Oral Medications: If the patient is unable to tolerate or absorb oral medications due to
severe nausea and vomiting, intravenous administration of antibiotics and supportive care in a hospital
setting may be required.
Non-Adherence to Outpatient Treatment: In cases where the patient is unlikely to adhere to outpatient
treatment or follow-up, hospitalization can ensure adequate delivery of antibiotics and close monitoring.
3. Subserous myomas are non-cancerous growths that develop in the outer layer of the uterus, known as the
serosa. The management of subserous myomas depends on various factors such as the size and location of the
myoma, the severity of symptoms, and the patient's reproductive goals.
Management options include:
15
•
•
•
Observation: If the subserous myoma is small, asymptomatic, and not causing any complications, it may be
monitored without intervention. Regular follow-up visits with a healthcare professional are important to
assess the growth and symptoms of the myoma.
Medications: Medications are not typically effective in directly shrinking or eliminating subserous myomas.
However, certain medications such as hormonal therapies, like gonadotropin-releasing hormone (GnRH)
agonists, may be used to manage symptoms associated with the myoma, such as heavy menstrual bleeding
or pain. These medications create a temporary state of hormonal suppression and can provide relief while
the medication is being taken.
Surgical Intervention: If the subserous myoma causes significant symptoms, grows in size, or interferes with
fertility or other organs, surgical management may be necessary. Surgical options for subserous myomas
include:
o Myomectomy: Myomectomy involves the surgical removal of the myoma while preserving the
uterus. This procedure is appropriate for women who wish to retain their fertility or have
symptomatic myomas that require removal. The surgery can be performed via open abdominal
surgery, laparoscopy, or hysteroscopy, depending on the size and location of the myoma.
o Hysterectomy: In cases where fertility is not a concern, or when other treatment options have been
unsuccessful or are contraindicated, a hysterectomy may be recommended. Hysterectomy involves
the removal of the uterus, including the myomas.
Variant 15
1. secondary amenorrhea: definition and causes ?
2. Myoma: investigations?
3. Bacterial Vaginosis : diagnostic criteria ?
1. Secondary amenorrhea refers to the absence of menstrual periods in a woman who previously had regular
menstrual cycles. It is diagnosed when a woman has missed her menstrual periods for three or more
consecutive cycles or for a duration of six months or longer. Secondary amenorrhea can be caused by various
factors, including:
o Pregnancy: The most common cause of secondary amenorrhea is pregnancy. It is important to rule out
pregnancy as a potential cause before further evaluation.
o Hormonal disorders: Hormonal imbalances can disrupt the normal menstrual cycle. Conditions such as
polycystic ovary syndrome (PCOS), hypothalamic amenorrhea (due to excessive exercise, stress, or low
body weight), thyroid disorders, and pituitary or ovarian disorders can lead to secondary amenorrhea.
o Structural abnormalities: Structural abnormalities of the reproductive organs, such as congenital
malformations, scarring of the uterus or cervix, or Asherman’s syndrome (intrauterine adhesions), can
interfere with menstrual bleeding.
o Medications and contraceptives: Certain medications, such as hormonal birth control methods (pills,
patches, injections), can cause temporary amenorrhea. Some medications, such as antipsychotics and
chemotherapy drugs, may also affect menstrual regularity.
o Chronic medical conditions: Chronic illnesses, such as diabetes, kidney disease, or autoimmune disorders,
can impact hormonal balance and menstrual function.
o Stress and lifestyle factors: Physical or emotional stress, excessive exercise, significant weight loss or gain,
and eating disorders can disrupt the hormonal signals responsible for menstruation.
2. Myoma, also known as uterine fibroids, are non-cancerous growths that develop in the uterus. Investigations
for myomas may include:
16
o
o
o
o
o
Pelvic ultrasound: This imaging technique uses sound waves to create images of the pelvic organs, allowing
visualization and measurement of uterine fibroids. Ultrasound can help determine the size, location, and
number of fibroids.
Magnetic Resonance Imaging (MRI): MRI may be recommended in certain cases to provide more detailed
information about the size, location, and characteristics of fibroids, especially when surgical treatment is
being considered.
Hysterosalpingography: This is an X-ray procedure that involves injecting a contrast dye into the uterus to
visualize the uterine cavity and fallopian tubes. It can help identify submucosal fibroids that protrude into
the uterine cavity.
Hysteroscopy: In this procedure, a thin, lighted tube called a hysteroscope is inserted through the cervix into
the uterus. It allows direct visualization of the uterine cavity and the detection of submucosal fibroids.
Endometrial biopsy: An endometrial biopsy may be performed to rule out other conditions that may cause
abnormal uterine bleeding, such as endometrial hyperplasia or cancer.
3. Bacterial vaginosis is diagnosed using the Amsel criteria or the Nugent score.
o The Amsel criteria include the presence of at least three of the following four criteria:
• Thin, white, or gray vaginal discharge that may have a fishy odor, especially after sexual intercourse.
• The vaginal pH is greater than 4.5 when tested using pH paper or a pH test swab.
• The presence of clue cells on microscopic examination of a vaginal discharge sample. Clue cells are
vaginal epithelial cells coated with bacteria, and their presence is indicative of BV.
• A positive whiff test result. This is performed by adding a drop of 10% potassium hydroxide (KOH)
solution to a vaginal discharge sample, which results in a characteristic fishy odor.
Variant 16
1. Primary amenorrhea : definition and causes ?
2. Fitz-Hugh-Curtis syndrome ?
3. PID: Tubo-ovarian abscess. Causes, diagnostics and management
1. Primary amenorrhea refers to the absence of menstrual periods in a woman who has reached the age of 16
without experiencing the onset of menstruation, or by the age of 14 without the development of secondary
sexual characteristics (such as breast development).
• It can be caused by various factors, including:
o Chromosomal abnormalities: Conditions such as Turner syndrome (where one of the X chromosomes is
missing or structurally abnormal) or Androgen Insensitivity Syndrome (AIS) can lead to primary amenorrhea.
o Structural abnormalities: Structural abnormalities of the reproductive system, such as congenital absence of
the uterus (Müllerian agenesis) or imperforate hymen, can prevent menstruation from occurring.
o Hormonal disorders: Hormonal imbalances can disrupt the normal menstrual cycle. Conditions such as
polycystic ovary syndrome (PCOS), hypothalamic or pituitary disorders, and congenital adrenal hyperplasia
(CAH) can result in primary amenorrhea.
o Chronic illnesses or genetic disorders: Certain chronic illnesses or genetic disorders, such as ovarian failure,
hypothyroidism, or adrenal gland disorders, can affect the function of the reproductive system and lead to
primary amenorrhea.
2. Fitz-Hugh-Curtis syndrome, also known as perihepatitis, is a rare complication of pelvic inflammatory disease
(PID).
• It is characterized by inflammation of the liver capsule and the surrounding tissues, typically caused by
the spread of infection from the pelvic area.
• The most common causative organism is Neisseria gonorrhoeae or Chlamydia trachomatis, which are
common pathogens associated with PID.
17
•
The syndrome presents with right upper quadrant abdominal pain that is often accompanied by
shoulder pain, which is referred pain from the diaphragm.
3. Tubo-ovarian abscess (TOA) is a severe complication of pelvic inflammatory disease (PID) characterized by a
collection of pus involving the fallopian tubes and ovaries.
Causes: Tubo-ovarian abscess typically arises from untreated or inadequately treated PID. The ascending infection
from the lower reproductive tract spreads to the fallopian tubes and ovaries, leading to the formation of an
abscess.
Diagnostics: The diagnosis of tubo-ovarian abscess may involve a combination of clinical evaluation, imaging studies,
and laboratory tests. Diagnostic methods include:
•
•
•
Pelvic examination: The healthcare provider may perform a pelvic examination to assess the pelvic organs for
tenderness, swelling, or masses.
Imaging studies: Transvaginal ultrasound and/or pelvic MRI may be used to visualize the abscess, assess its size,
and determine the involvement of surrounding structures.
Laboratory tests: Blood tests may be done to assess inflammation markers, such as C-reactive protein (CRP) and
white blood cell count (WBC), which may be elevated in the presence of an abscess.
Management: The management of tubo-ovarian abscess typically involves a combination of medical therapy and
sometimes surgical intervention. The treatment may include:
•
•
•
Antibiotics: Intravenous (IV) antibiotics are usually administered to target the infection and reduce
inflammation. The specific choice of antibiotics depends on the suspected or identified causative organisms.
Drainage: In some cases, if the abscess is large, persistent, or associated with severe symptoms, drainage may
be necessary. This can be done through image-guided percutaneous drainage or surgical intervention, such as
laparoscopic or open surgical drainage.
Follow-up: Close follow-up with healthcare providers is essential to monitor response to treatment, assess for
complications, and ensure complete resolution of the abscess.
Variant 17
1. PID: symptoms
2. fibroid: indications for medical treatment
3. infertility: investigations
1. PID: Common symptoms include:
•
•
•
•
•
•
Lower abdominal pain or pelvic pain: This pain may be dull, constant, or intermittent. It is often felt in the
lower abdomen or pelvis and may be more pronounced during sexual intercourse or menstruation.
Abnormal vaginal discharge: An increase in vaginal discharge that may have an unusual color (yellow,
green), consistency (thick, foul-smelling), or quantity is a common symptom of PID.
Painful urination: Some individuals with PID may experience pain or discomfort during urination.
Abnormal uterine bleeding: PID can cause irregular menstrual bleeding, such as heavy or prolonged
periods, spotting between periods, or postcoital bleeding.
Painful sexual intercourse: Pain or discomfort during sexual intercourse, known as dyspareunia, is often
reported by individuals with PID.
Fever: A low-grade or high-grade fever may accompany PID. The presence of fever suggests an inflammatory
response and systemic involvement.
18
•
•
Fatigue and general malaise: Feeling tired, rundown, or generally unwell can be associated with PID.
Tenderness during pelvic examination: The healthcare provider may observe tenderness or pain upon
palpation of the pelvic organs during a pelvic examination.
2. Fibroids, also known as uterine leiomyomas, are non-cancerous growths that develop in the uterus.
Indications for medical treatment of fibroids include:
• Symptomatic Relief: Medical treatment may be recommended to alleviate symptoms associated with
fibroids, such as heavy menstrual bleeding, pelvic pain or pressure, and urinary frequency or urgency.
• Preoperative Management: In cases where surgical intervention, such as myomectomy or hysterectomy, is
planned, medical treatment may be used to shrink the fibroids and reduce the size of the uterus, making
the surgery technically easier and potentially minimizing blood loss.
• Fertility Preservation: In women who wish to preserve their fertility and conceive, medical treatment may
be considered to manage symptoms and reduce the size of the fibroids, potentially improving fertility
outcomes.
• Unfavorable Surgical Candidates: For individuals who are not suitable candidates for surgery due to medical
reasons or personal preference, medical treatment can be a viable alternative to manage symptoms and
slow down the growth of fibroids.
Medical treatments for fibroids may include:
•
•
•
Hormonal medications: Hormonal therapies, such as oral contraceptives, progestins, or gonadotropinreleasing hormone (GnRH) agonists, may be used to regulate the menstrual cycle, reduce heavy bleeding,
and temporarily shrink the fibroids.
Nonsteroidal anti-inflammatory drugs (NSAIDs): NSAIDs can help alleviate pain associated with fibroids and
reduce menstrual bleeding.
Selective progesterone receptor modulators (SPRMs): SPRMs, such as ulipristal acetate, can help reduce
fibroid size and control bleeding.
3. Investigations performed for infertility:
•
•
•
•
•
•
•
Medical History and Physical Examination: A detailed medical history and physical examination of both
partners help identify factors that could contribute to infertility, such as prior surgeries, sexually transmitted
infections, menstrual history, and medication use.
Semen Analysis: This test evaluates the quality and quantity of sperm. It assesses sperm count, motility,
and morphology to identify potential male factor infertility.
Ovulation Assessment: Various methods, including tracking menstrual cycles, basal body temperature
charting, hormonal assessment, and ultrasound monitoring of ovarian follicle development, help assess
ovulation and identify ovulation disorders.
Tubal Patency Testing: Tests such as hysterosalpingography (HSG) or laparoscopy with chromotubation
assess the patency of the fallopian tubes to determine if there are any blockages or damage that could
hinder fertilization.
Hormonal Assessments: Blood tests to measure levels of reproductive hormones such as follicle-stimulating
hormone (FSH), luteinizing hormone (LH), estradiol, and progesterone help evaluate hormonal imbalances
that could affect ovulation and overall reproductive function.
Imaging Studies: Transvaginal ultrasound helps assess the uterus and ovaries, detect abnormalities such as
fibroids or ovarian cysts, and evaluate the overall reproductive health.
Additional Tests: Depending on the specific circumstances, additional tests may be recommended, such as
genetic testing, infectious disease screening, or specialized procedures like hysteroscopy or laparoscopy to
evaluate the reproductive organs directly.
Variant 18
1. Atypical symptoms of endometriosis.
19
2. Ectopic pregnancy : risk factors ?
3. AUB in postmenopause: causes and investigations ?
1. Atypical symptoms may include:
• Gastrointestinal symptoms: Endometriosis can affect the digestive system, leading to symptoms such as bloating,
constipation, diarrhea, nausea, and pain during bowel movements.
• Urinary symptoms: Some women with endometriosis may experience urinary symptoms, including frequent
urination, urgency, pain or discomfort during urination, and even blood in the urine.
• Fatigue and chronic pain: Endometriosis can cause chronic fatigue and general feelings of tiredness. Additionally,
it may lead to generalized pelvic pain or pain in other areas such as the lower back, thighs, or abdomen.
• Pain during intercourse: Painful intercourse, known as dyspareunia, can be a symptom of endometriosis. It may
occur during or after sexual activity.
2. Ectopic pregnancy : These risk factors include:
• Previous ectopic pregnancy: Women who have had an ectopic pregnancy in the past are at an increased risk of
having another.
• Pelvic inflammatory disease (PID): Inflammation and scarring of the fallopian tubes due to untreated or
recurrent pelvic infections, such as those caused by sexually transmitted infections (STIs), can increase the risk of
ectopic pregnancy.
• Previous surgery or tubal damage: Surgery on the fallopian tubes, such as a tubal ligation or surgery to treat
previous ectopic pregnancy, can increase the risk of future ectopic pregnancies. Similarly, any damage or
abnormalities in the fallopian tubes can also increase the risk.
• Reproductive system abnormalities: Certain structural abnormalities of the reproductive system, such as
congenital anomalies or birth defects, can increase the risk of ectopic pregnancy.
• Fertility treatments: Assisted reproductive techniques, such as in vitro fertilization (IVF), can slightly increase the
risk of ectopic pregnancy.
• Age and smoking: Ectopic pregnancy is more common in women over 35 years of age. Smoking also increases
the risk.
3. Abnormal uterine bleeding (AUB) in postmenopause refers to any vaginal bleeding that occurs after a woman has
reached menopause, which is defined as the absence of menstrual periods for 12 consecutive months.
Common causes of AUB in postmenopause include:
• Hormonal imbalance: Fluctuations in hormone levels, such as estrogen and progesterone, can lead to
irregular bleeding. This may occur due to residual ovarian function or hormonal imbalances within the body.
• Endometrial atrophy: After menopause, the lining of the uterus (endometrium) becomes thin and fragile.
This can make it more prone to bleeding.
• Endometrial hyperplasia or polyps: Postmenopausal bleeding may be caused by overgrowth of the
endometrial tissue (hyperplasia) or the presence of polyps. These conditions can be associated with an
increased risk of developing endometrial cancer.
Investigations:
•
•
Transvaginal ultrasound: This imaging technique uses sound waves to create images of the pelvic organs,
including the uterus and ovaries. It can help evaluate the thickness of the endometrium, identify any structural
abnormalities, and detect the presence of polyps or masses.
Endometrial biopsy: A biopsy involves taking a small sample of the endometrial tissue for laboratory analysis. It
can help evaluate the cellular composition of the endometrium and identify any abnormal cells or signs of
endometrial hyperplasia or cancer.
20
•
•
Hysteroscopy: In this procedure, a thin, lighted tube called a hysteroscope is inserted through the cervix into the
uterus. It allows direct visualization of the uterine cavity and can help identify any abnormalities, such as polyps,
fibroids, or other lesions.
Measurement of serum hormone levels: Blood tests may be performed to assess hormone levels, including
estradiol (E2) and follicle-stimulating hormone (FSH). These tests can provide information about hormonal
imbalances that may be contributing to the abnormal bleeding.
Variant 19
1. AUB: causes of dysfunctional uterine bleeding ?
2. PID: investigations ?
3. Ovarian reserve: definition and tests ?
1. Dysfunctional uterine bleeding (DUB) refers to abnormal uterine bleeding that occurs in the absence of organic
pathology or specific hormonal abnormalities. The exact cause of DUB is not fully understood, but it is believed
to be related to hormonal imbalances and disruptions in the normal menstrual cycle. Some possible causes of
dysfunctional uterine bleeding include:
• Hormonal imbalances: Fluctuations in hormone levels, particularly estrogen and progesterone, can disrupt the
normal growth and shedding of the uterine lining, leading to irregular or heavy bleeding.
• Anovulation: Failure to release an egg during the menstrual cycle (anovulation) can result in hormonal
imbalances and irregular bleeding.
• Polycystic ovary syndrome (PCOS): PCOS is a hormonal disorder characterized by multiple cysts on the ovaries. It
can cause irregular menstrual cycles and dysfunctional uterine bleeding.
• Thyroid disorders: Abnormalities in thyroid hormone levels can affect the menstrual cycle and contribute to
dysfunctional uterine bleeding.
• Uterine abnormalities: Structural abnormalities of the uterus, such as polyps, fibroids, or adenomyosis, can lead
to irregular bleeding.
2. The investigations for PID may include:
• Physical examination: A healthcare provider may perform a pelvic examination to assess for tenderness,
swelling, or masses in the pelvic region.
• Laboratory tests: Blood tests can be conducted to check for signs of infection, such as an elevated white blood
cell count. Additionally, testing for specific pathogens like Neisseria gonorrhoeae or Chlamydia trachomatis may
be done.
• Pelvic ultrasound: This imaging test uses sound waves to create images of the pelvic organs. It can help detect
abnormalities such as fluid-filled fallopian tubes, abscesses, or other structural changes.
• Endometrial biopsy: A sample of the uterine lining may be taken for laboratory analysis to check for signs of
infection or inflammation.
• Laparoscopy: In certain cases, a minimally invasive surgical procedure called laparoscopy may be performed. It
allows direct visualization of the pelvic organs and can help confirm the diagnosis of PID and assess the extent of
damage.
3. Ovarian reserve refers to the quantity and quality of a woman’s remaining eggs (oocytes) within her ovaries. It
provides an indication of a woman’s fertility potential. As women age, the ovarian reserve gradually declines.
Various factors can affect ovarian reserve, including genetic factors and certain medical conditions.
Tests used to assess ovarian reserve include:
21
•
•
•
Anti-Mullerian Hormone (AMH) test: AMH is a hormone produced by the developing ovarian follicles. The blood
test measures the level of AMH, which is an indicator of the number of follicles remaining in the ovaries.
Follicle-Stimulating Hormone (FSH) test: FSH is a hormone released by the pituitary gland that stimulates the
growth and development of ovarian follicles. An elevated FSH level, especially when tested on specific days of the
menstrual cycle, may indicate diminished ovarian reserve.
Antral follicle count: This test uses ultrasound to count the number of small, developing follicles in the ovaries. It
is typically performed early in the menstrual cycle.
Variant 20
1. Myoma and adenomyosis: differential diagnosis?
2. Ectopic pregnancy: investigations
3. STI Diseases
1. Myoma, also known as uterine fibroids, and adenomyosis are two common conditions that can cause similar
symptoms and affect the uterus. However, they have distinct characteristics that aid in their differential diagnosis.
•
•
•
Myoma (Uterine Fibroids): Myomas are noncancerous growths that develop in the muscle tissue of the uterus.
They can vary in size, number, and location within the uterus. Common symptoms include heavy or prolonged
menstrual bleeding, pelvic pain or pressure, frequent urination, and reproductive issues. During a physical
examination, myomas may be felt as firm, round, or lumpy masses in the uterine wall.
Adenomyosis: Adenomyosis occurs when the tissue lining the uterus (endometrium) grows into the muscular
wall of the uterus. This condition can cause an enlarged and tender uterus, as well as heavy, prolonged, and
painful menstrual bleeding. Adenomyosis can also contribute to infertility or pregnancy complications. The
definitive diagnosis is typically made through a combination of imaging studies, such as ultrasound or magnetic
resonance imaging (MRI), and histopathological examination of the uterine tissue obtained through a biopsy.
The differential diagnosis between myoma and adenomyosis can be challenging because the two conditions can
coexist or have overlapping symptoms. Imaging studies, such as ultrasound or MRI, can help differentiate
between them by evaluating the location, size, and characteristics of the uterine abnormalities.
2. Ectopic pregnancy occurs when a fertilized egg implants and develops outside the uterus, most commonly in the
fallopian tubes. Several investigations can aid in the diagnosis of ectopic pregnancy, including:
•
•
•
Transvaginal Ultrasound: Transvaginal ultrasound is the primary imaging modality used to diagnose ectopic
pregnancy. It allows visualization of the uterus and fallopian tubes, enabling the identification of an ectopic
pregnancy, gestational sac, or abnormal findings such as fluid accumulation in the pelvis.
Quantitative hCG (Human Chorionic Gonadotropin): Serial measurement of blood levels of hCG, a hormone
produced during pregnancy, can provide valuable information. In a normal pregnancy, hCG levels typically
double every 48 to 72 hours. Slower-than-expected hCG rise or plateauing levels may indicate a potential
ectopic pregnancy.
Culdocentesis: Culdocentesis involves the insertion of a needle into the space behind the vagina (cul-de-sac) to
detect the presence of blood or fluid, which could suggest a ruptured ectopic pregnancy. However, this
procedure is less commonly used nowadays due to the availability of more accurate imaging techniques.
3. STI (Sexually Transmitted Infection) diseases are infections primarily transmitted through sexual contact. They
can be caused by bacteria, viruses, parasites, or fungi.
some commonly encountered STI diseases:
• Chlamydia: Chlamydia trachomatis is a bacterial infection that can be transmitted through sexual activity. It often
presents without symptoms, making it crucial to undergo regular screening, especially for sexually active
22
•
•
•
•
individuals. Laboratory testing for chlamydia typically involves a urine sample or swab from the affected area,
such as the cervix, urethra, or rectum. Nucleic acid amplification tests (NAATs) are commonly used to detect the
presence of chlamydia DNA.
Gonorrhea: Neisseria gonorrhoeae is the bacterium responsible for gonorrhea, which is also transmitted through
sexual activity. Similar to chlamydia, gonorrhea can be asymptomatic. Testing methods involve urine samples,
swabs from the urethra, cervix, rectum, or throat, and NAATs to detect the presence of the bacteria.
Syphilis: Syphilis is a bacterial infection caused by Treponema pallidum. It can be transmitted through sexual
contact or from mother to child during pregnancy. Syphilis has different stages, each with its own symptoms.
Laboratory testing for syphilis typically includes blood tests, such as the non-treponemal test (e.g., Venereal
Disease Research Laboratory, VDRL) followed by treponemal tests (e.g., Treponema pallidum particle
agglutination assay, TPPA) for confirmation.
Human Immunodeficiency Virus (HIV): HIV is a viral infection that attacks the immune system. It is primarily
transmitted through sexual contact, sharing needles, or mother-to-child transmission during childbirth or
breastfeeding. Laboratory testing for HIV involves blood tests to detect HIV antibodies or antigens. Rapid tests,
enzyme immunoassays (EIAs), and Western blot tests are commonly used.
Genital Herpes: Genital herpes is caused by the herpes simplex virus (HSV), which can be transmitted through
sexual activity. Laboratory testing for genital herpes involves collecting samples from the affected area during an
active outbreak and performing polymerase chain reaction (PCR) or viral culture to detect the presence of the
virus.
23